Bank of New York Mellon’s Sophiris Bio, Inc. SPHS Stock Holding History
Bought
Maintained
Sold
Other funds holding SPHS
HP
PAI
SM
BO
ACM
ARTA
Bank of New York Mellon's SPHS Position: Q2 2019 in Review
Bank of New York Mellon sold out of Sophiris Bio, Inc. (SPHS) in Q2 2019, closing a stake of 23,518 shares — an estimated $23K sold.
Bank of New York Mellon first reported a position in SPHS in Q1 2014 and held it in 21 quarters. The position peaked at $95K in Q3 2018. 22 funds tracked by Wall St. Rank hold SPHS as of Q2 2019.
- Bank of New York Mellon reported no remaining Sophiris Bio, Inc. position as of Q2 2019 after selling out during the quarter.
- Bank of New York Mellon sold 23,518 Sophiris Bio, Inc. shares in Q2 2019, an estimated $23K.
- Bank of New York Mellon first reported a position in Sophiris Bio, Inc. in Q1 2014 and held it in 21 quarters.
- Bank of New York Mellon's Sophiris Bio, Inc. position peaked at $95K in Q3 2018.
- 22 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2019.
Based on Bank of New York Mellon's 13F filing for Q2 2019, filed 12 Aug 2019.